Article Information
History
- May 26, 2022.
Article Versions
- You are currently viewing Version 1 of this article (May 26, 2022 - 15:48).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Thomas Gilliland, MD1,2,3,
- Jaqueline S. Dron, PhD1,2,
- Margaret Sunitha Selvaraj, PhD1,2,3,
- Mark Trinder, BA4,5,
- Kaavya Paruchuri, MD1,2,3,
- Sarah M. Urbut, MD PhD1,2,3,
- Sara Haidermota, BA1,2,
- Rachel Bernardo, BS1,2,
- Md Mesbah Uddin, PhD1,2,
- Michael C. Honigberg, MD MPP1,2,3,
- Gina Peloso, PhD6 and
- Pradeep Natarajan, MD, MMSc1,2,3,*
- 1Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA
- 2Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard and MIT, Cambridge, MA
- 3Department of Medicine, Harvard Medical School, Boston, MA
- 4Centre for Heart Lung Innovation, University of British Columbia, Vancouver
- 5Program in Medical and Population Genetics and the Cardiovascular Disease Initiative, Broad Institute of Harvard, Cambridge, Massachusetts
- 6Department of Biostatistics, Boston University School of Public Health, Boston, MA
- ↵*Please address correspondence to: Pradeep Natarajan, MD, MMSc, 55 Fruit Street, Boston, Massachusetts 02145, pnatarajan{at}mgh.harvard.edu, 617-726-1843
Posted May 26, 2022.
Genetic Architecture And Clinical Outcomes Of The Fredrickson-Levy-Lees Dyslipoproteinemias
